Gambacorta, Maria Antonietta
 Distribuzione geografica
Continente #
NA - Nord America 6.737
EU - Europa 6.286
AS - Asia 1.468
AF - Africa 83
SA - Sud America 32
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 14
Totale 14.645
Nazione #
US - Stati Uniti d'America 6.708
DE - Germania 1.877
SE - Svezia 1.449
IT - Italia 962
CN - Cina 762
IE - Irlanda 442
FR - Francia 356
UA - Ucraina 343
SG - Singapore 306
GB - Regno Unito 211
IN - India 189
FI - Finlandia 148
RU - Federazione Russa 146
PL - Polonia 109
BE - Belgio 85
TR - Turchia 64
CI - Costa d'Avorio 62
CZ - Repubblica Ceca 46
HK - Hong Kong 33
IR - Iran 27
NL - Olanda 21
JP - Giappone 20
AU - Australia 19
CA - Canada 18
PE - Perù 17
CH - Svizzera 16
AT - Austria 14
IL - Israele 12
RO - Romania 12
BR - Brasile 10
DZ - Algeria 10
ES - Italia 10
ID - Indonesia 9
PH - Filippine 9
A2 - ???statistics.table.value.countryCode.A2??? 7
EU - Europa 7
GR - Grecia 7
MX - Messico 7
NO - Norvegia 6
NZ - Nuova Zelanda 6
RS - Serbia 6
AE - Emirati Arabi Uniti 4
BH - Bahrain 4
CL - Cile 4
DK - Danimarca 4
EG - Egitto 4
MT - Malta 4
AM - Armenia 3
BG - Bulgaria 3
KR - Corea 3
KZ - Kazakistan 3
MY - Malesia 3
PA - Panama 3
PK - Pakistan 3
VN - Vietnam 3
IQ - Iraq 2
PT - Portogallo 2
SA - Arabia Saudita 2
SC - Seychelles 2
AL - Albania 1
CR - Costa Rica 1
EC - Ecuador 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
MW - Malawi 1
OM - Oman 1
QA - Qatar 1
TH - Thailandia 1
TW - Taiwan 1
VA - Santa Sede (Città del Vaticano) 1
Totale 14.645
Città #
Chandler 1.788
Ashburn 530
Dublin 440
New York 284
Ann Arbor 273
Jacksonville 249
San Mateo 245
Milan 191
Rome 182
Singapore 172
Wilmington 170
Princeton 146
Nanjing 139
Nürnberg 131
Boston 127
Beijing 117
Marseille 117
Moscow 115
Bremen 114
Cattolica 111
Dearborn 109
Woodbridge 102
Fairfield 96
Houston 91
Warsaw 86
Redwood City 82
Los Angeles 80
Brussels 79
Helsinki 68
Lawrence 64
Abidjan 62
Seattle 56
Izmir 52
Nanchang 50
Leawood 47
Munich 42
Boardman 41
Washington 40
Zhengzhou 39
Chicago 37
Shenyang 37
Brno 35
Detroit 32
Augusta 31
Falls Church 30
Norwalk 30
Pune 28
Hebei 27
Kunming 26
Hong Kong 22
Hangzhou 21
Jiaxing 21
Cambridge 20
Fremont 20
London 20
Lancaster 19
Mountain View 19
Phoenixville 19
Lima 17
Tianjin 17
University Park 17
Redmond 16
San Diego 16
Andover 15
Changsha 15
Hefei 15
Kraków 15
Kish 14
Guangzhou 13
Ningbo 13
Shanghai 13
Vienna 13
Frankfurt am Main 12
Jinan 12
Paris 12
Phoenix 12
Verona 10
Atlanta 8
Brescia 8
Lappeenranta 8
Naples 8
Renton 8
Sacramento 8
Simi Valley 8
Berlin 7
Castelnuovo 7
Cedar Knolls 7
Chengdu 7
San Francisco 7
Toronto 7
Belgrade 6
Cuauhtémoc 6
Monmouth Junction 6
Tettnang 6
Tokyo 6
Wuhan 6
Amsterdam 5
Ardabil 5
Busto Arsizio 5
Changchun 5
Totale 7.842
Nome #
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 305
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 212
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 197
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 173
Multimodality treatment of unresectable stage III non small cell lung cancer: interim analysis of a phase II trial using preoperative gemcitabine with concurrent radiotherapy 164
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 164
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 164
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 161
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 161
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 158
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 156
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 143
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 142
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 137
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 132
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 132
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 131
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 127
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 126
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 125
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 124
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 120
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 118
Lung recruitment strategies and surfactant in neonatal intensive care unit 116
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 114
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 114
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 111
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer 111
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 109
Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial. 106
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 105
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 104
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. 104
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 102
Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases 100
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 98
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 97
An umbrella protocol for standardized data collection (SDC) in rectal cancer: a prospective uniform naming and procedure convention to support personalized medicine 97
Virtual simulation:fifteen years later 93
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum 88
Nomogram predicting response after chemoradiotherapy in rectal cancer using sequential PETCT imaging: A multicentric prospective study with external validation. 86
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 86
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 84
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma 84
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 84
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. 82
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 82
Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study 2: the role of ultrasound after chemoradiation to assess residual tumor 82
Generator breast datamart—the novel breast cancer data discovery system for research and monitoring: Preliminary results and future perspectives 82
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 81
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 81
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 80
IGRT in rectal cancer. 79
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 79
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 77
Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach 77
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 77
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 76
The INTER-ROMA project--a survey among Italian radiation oncologists on their approach to the treatment of bone metastases 75
Postoperative 5-FU based radiochemotherapy in rectal cancer: retrospective long term results and prognostic factors of a pooled analysis on 1,338 patients 75
Possible contribution of IMRT in postoperative radiochemotherapy for rectal cancer: Analysis on 1798 patients by prediction model 75
Standardized data collection to build prediction models in oncology: A prototype for rectal cancer 74
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 73
Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications 72
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 72
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 71
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 71
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 70
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 70
The assisi think tank meeting breast large database for standardized data collection in breast cancer—attm.Blade 70
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 69
Could the surgeon trust to radiotherapy help in rectal cancer? 68
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 67
Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer 66
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 66
The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. 66
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 66
The role of local excision in rectal cancer after complete response to neoadjuvant treatment 66
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 65
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 65
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 64
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 64
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 64
A radiotherapy staff experience of gratitude during COVID-19 pandemic 64
Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging. 63
Avatar: Analysis for visual acuity prediction after eye interventional radiotherapy 63
EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe 62
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 62
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 62
Low Tesla magnetic resonance guided radiotherapy for locally advanced cervical cancer: first clinical experience 61
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 61
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development 61
Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer 61
Avatar: Analysis for visual acuity prediction after eye interventional radiotherapy 60
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 60
The Safety of Radiotherapy in the Treatment of Primary Cutaneous B-Cell Lymphoma: A Multidisciplinary Systematic Review 60
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 60
Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: Short-term results of a multicentric study 59
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper. 59
Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An in silico evaluation 59
Totale 9.561
Categoria #
all - tutte 68.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.234 0 90 55 47 112 121 152 55 178 62 265 97
2020/20211.094 85 102 28 109 169 52 111 31 128 68 162 49
2021/20222.024 181 77 35 166 86 72 32 268 133 143 446 385
2022/20234.982 649 651 372 773 278 591 261 395 587 153 194 78
2023/20242.659 108 690 127 186 130 462 164 94 31 97 280 290
2024/2025168 113 55 0 0 0 0 0 0 0 0 0 0
Totale 14.962